Ogiwara Hideki, Nordli Douglas R, DiPatri Arthur J, Alden Tord D, Bowman Robin M, Tomita Tadanori
Division of Neurosurgery, Children's Memorial Hospital, Chicago, Illinois, USA.
J Neurosurg Pediatr. 2010 Mar;5(3):271-6. doi: 10.3171/2009.10.PEDS09372.
OBJECT: Ganglioglioma is the most common neoplasm causing focal epilepsy, accounting for approximately 40% of all epileptogenic tumors and for 1-4% of all pediatric CNS tumors. The optimal surgical treatment for pediatric epileptogenic ganglioglioma has not been fully established. The authors present their experience in the surgical management of these lesions. METHODS: The authors retrospectively analyzed seizure outcome and surgical results of pediatric patients with ganglioglioma treated with resection. The patients' charts were reviewed for demographic data, clinical presentation, surgical therapy, and follow-up. RESULTS: The 30 patients (17 boys, 13 girls) had a history of medically intractable epilepsy. Total resection of tumor was achieved with or without adjacent epileptogenic tissue resection in all patients except 1, who underwent cyst fenestration and biopsy. Intraoperative electrocorticography (ECoG) was used in 21 patients. If an active spike focus or profound attenuation was observed in adjacent tissues, resection of those tissues was performed in addition to complete tumor resection (lesionectomy). The interval between onset of seizures and surgery ranged from 1 month to 9 years (mean 1.6 years). Patient age at the time of surgery ranged from 9 months to 16.3 years (mean 8.6 years). Twenty-five patients (83.3%) had complex partial seizures and 5 (16.7%) had simple partial seizures. Eighteen tumors (60%) were temporal (14 temporomesial, 4 temporolateral), and 12 (40%) were extratemporal. The mean follow-up period was 3.4 years (range 1 month-8.16 years). In 2 cases (6.7%), tumor recurrence was observed. Outcome was Engel Class I in 27 cases (90.0%; 14 temporomesial, 4 temporolateral, 9 extratemporal) and Engel Class II in 3 (10.0%; all extratemporal). Tumor resection allowed good seizure control, especially in the 18 cases of temporal ganglioglioma (all Engel Class I postoperatively). Eleven patients underwent removal of extratumoral epileptogenic tissue (anterior temporal neocortex resection in 10, anterior temporal neocortex resection with anterior hippocampectomy in 1) in addition to lesionectomy using intraoperative ECoG. CONCLUSIONS: Lesionectomy with adjacent temporal neocortex resection using intraoperative ECoG provided good seizure control of pediatric temporal ganglioglioma. For extratemporal ganglioglioma, lesionectomy alone can provide fairly good seizure control. Considering the memory function of the hippocampus, lesionectomy with adjacent temporal neocortical resection can be a safe, feasible, and effective treatment option for epileptogenic gangliogliomas in pediatric patients.
目的:神经节细胞胶质瘤是引起局灶性癫痫最常见的肿瘤,约占所有致痫性肿瘤的40%,占所有儿童中枢神经系统肿瘤的1% - 4%。小儿致痫性神经节细胞胶质瘤的最佳手术治疗方法尚未完全确立。作者介绍了他们对这些病变进行手术治疗的经验。 方法:作者回顾性分析了接受肿瘤切除术治疗的小儿神经节细胞胶质瘤患者的癫痫发作结局和手术结果。查阅患者病历以获取人口统计学数据、临床表现、手术治疗及随访情况。 结果:30例患者(17例男孩,13例女孩)有药物难治性癫痫病史。除1例行囊肿开窗活检外,所有患者均实现了肿瘤全切,无论是否切除了相邻的致痫组织。21例患者术中使用了皮质脑电图(ECoG)。如果在相邻组织中观察到活跃的棘波灶或明显衰减,则除了完整切除肿瘤(病灶切除术)外,还对这些组织进行切除。癫痫发作开始至手术的间隔时间为1个月至9年(平均1.6年)。手术时患者年龄为9个月至16.3岁(平均8.6岁)。25例患者(83.3%)有复杂部分性发作,5例(16.7%)有简单部分性发作。18个肿瘤(60%)位于颞叶(14个颞叶内侧,4个颞叶外侧),12个(40%)位于颞叶外。平均随访期为3.4年(范围1个月至8.16年)。2例(6.7%)观察到肿瘤复发。27例患者(90.0%)的结局为恩格尔I级(14个颞叶内侧,4个颞叶外侧,9个颞叶外),3例(10.0%)为恩格尔II级(均为颞叶外)。肿瘤切除可实现良好的癫痫控制,尤其是在18例颞叶神经节细胞胶质瘤患者中(术后均为恩格尔I级)。11例患者除病灶切除术外,还使用术中ECoG切除了肿瘤外致痫组织(10例行颞叶新皮质前部切除术,1例行颞叶新皮质前部切除术加海马前部切除术)。 结论:术中使用ECoG行病灶切除术并切除相邻的颞叶新皮质可有效控制小儿颞叶神经节细胞胶质瘤的癫痫发作。对于颞叶外神经节细胞胶质瘤仅行病灶切除术即可提供较好的癫痫控制。考虑到海马的记忆功能,病灶切除术并切除相邻的颞叶新皮质对于小儿致痫性神经节细胞胶质瘤可能是一种安全、可行且有效的治疗选择。
J Neurosurg Pediatr. 2010-3
Acta Neurochir (Wien). 2012-1-5
J Clin Neurosci. 2006-6
J Neurosurg Pediatr. 2010-1
Neurosurgery. 2012-6
J Neurosurg. 2005-4
Minerva Pediatr. 2013-12
Childs Nerv Syst. 2024-10
Cochrane Database Syst Rev. 2019-6-25